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Abstract 
Background 
The measurement of urinary biomarkers during ex-vivo normothermic kidney perfusion 
(EVKP) may aid in the assessment of a kidney prior to transplantation. This study measured 
levels of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-
1) and endothelin-1 (ET-1) during EVKP in a series of discarded human kidneys. 
Methods 
Fifty six kidneys from deceased donors were recruited into the study. Each kidney underwent 
60 minutes of EVKP and was scored based on the macroscopic appearance, renal blood flow 
and urine output. The scores ranged from 1 (least injury) to 5 (most severe). Levels of oxygen 
consumption, extraction, creatinine fall and fractional excretion of sodium were measured 
during perfusion. Urinary levels of NGAL, KIM-1 and ET-1 were measured after EVKP. 
Results 
Thirty eight kidneys had an EVKP score of 1 or 2, 8 a score of 3 and 10 a score of 4 or 5.  
During EVKP lower levels of oxygen consumption, higher oxygen extraction, a lower 
decrement of  serum creatinine and higher levels of NGAL and ET-1 were associated with a 
higher EVKP score (P<0.05). These parameters were also associated with a raised creatinine 
level in the donor before organ retrieval. Levels of KIM-1 were not associated with the 
perfusion parameters (P=0.649) or renal function in the donor (R2=0.02458: P=0.271).  
Conclusion 
The measurement of urinary biomarkers, particularly NGAL in combination with functional 
perfusion parameters and the EVKP score provides an informative measure of kidney quality 
which may aid the decision to transplant the kidney. 
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Introduction 
Perfusion technologies provide a means to assess the quality of an organ prior to 
transplantation. This can aid in the decision process, preventing the likelihood of primary non 
function (PNF) and also the unnecessary discard of the organ. Hypothermic perfusion 
techniques have proved useful in determining the level of injury but perfusion parameters 
(flow and resistance) are poor predictors of outcome and cannot reliably discriminate 
between organs that should or should not be transplanted 1. 
Normothermic perfusion technologies have significant advantages over hypothermic 
techniques. Graft function is restored and the exposure to cold ischaemia is lessened. 
Furthermore, an assessment of functional parameters during perfusion not only allows a 
measure of injury but also provides an evaluation of recovery. We have previously described 
the application of an ex-vivo normothermic kidney perfusion (EVKP) quality assessment 
score in clinical transplantation 2. The assessment score is based on 3 basic parameters during 
perfusion: Macroscopic appearance, renal blood flow and urine output. Kidneys are scored 
from 1 (least injury) to 5 (the most severe injury). Other markers of function and injury may 
also be incorporated into the assessment to provide a more comprehensive measure of 
quality. 
Urinary biomarkers are emerging as an important diagnostic aid in the early detection 
of acute kidney injury (AKI) in a wide range of settings 3-5. Neutrophil gelatinase-associated 
lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) are 2 of the most recognised and 
reliable markers of kidney injury and point-of-care devices are available to provide results for 
both within 10 to 15 minutes. Endothelin-1 is a non-renal specific marker of tissue injury. 
Nevertheless, we have previously found it to be a reliable index of tubular injury in a porcine 
model 6, 7.  
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The aim of this study was to examine the relationship between urinary biomarkers 
[endothelin-1 (ET-1), neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury 
molecule-1 (KIM-1)] and EVKP parameters in a series of human kidneys that were rejected 
for transplantation in the UK.  
 
Materials and Methods 
Ethical approval 
From December 2012 to January 2014, 56 kidneys from the national organ allocation 
scheme that were deemed unsuitable for transplantation were recruited in this research 
project. Consent for the use of the organs for transplantation and research was obtained from 
the donor family by the Specialist Nurses in Organ Donation before organ retrieval. Ethical 
approval was granted for the study by the national research ethics commission in the UK, 
National Research Ethics System (12/EM/0143). 
 
Kidney Donor 
Kidneys were retrieved by the UK National Organ Retrieval Service as previously 
described 2. The kidney donor information was recorded and included donor age, gender, 
donor type and terminal serum creatinine levels. The warm and cold ischaemic times were 
also recorded. 
 
Ex-vivo normothermic perfusion and functional analyses 
Kidneys were prepared for EVKP and the renal artery, vein and ureter cannulated. 
The EVKP circuit was primed with a perfusate solution (Ringer’s solution, Baxter 
Healthcare) and supplements added to provide a physiological environment 8, 9. One unit of 
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
6 
 
group 0 positive packed red blood cells from the local blood bank was added to the priming 
solution.  
Kidneys were perfused with the red cell based solution at a set mean arterial pressure 
and near normal body temperature. Supplements were infused into the venous reservoir and 
arterial arm of the circuit to maintain normal homeostatic conditions as previously described 
2, 8-10. 
Creatinine was added to the red cell based perfusate to allow an assessment of 
creatinine clearance and tubular function. The renal blood flow and mean arterial pressure 
were recorded continuously and the mean calculated. Urine output was collected throughout 
perfusion and the total output measured. Blood gas analysis of arterial and venous blood was 
used to record acid-base homeostasis and measure oxygen consumption and extraction. Blood 
samples were taken pre-perfusion and after 60 minutes of EVKP. A urine sample was 
collected after 60 minutes of EVKP. Percentage creatinine fall and fractional excretion of 
sodium were calculated and recorded.  
 
Urinary biomarkers 
Urine levels of endothelin 1 (ET-1) were determined using an enzyme immunometric 
assay kit (Assay Design. Michigan. USA). Levels of NGAL and KIM-1 were measured using 
a Human NGAL sandwich enzyme-linked immunosorbent assay (ELISA) kit (BioPorto 
Diagnostics, Gentofte. Denmark) and KIM-1 ELISA kit (Enzo Life Sciences, Exeter, UK). 
The samples and standards were added in duplicate to the precoated plates and the assays 
carried out as per the manufacturer’s instructions.  
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EVKP assessment parameters  
Macroscopic assessment 
Each kidney was categorised into 3 groups according to its macroscopic appearance 
during EVKP as follows 2. 
Grade I: Excellent perfusion (global pink appearance – 1 point) 
Grade II: Moderate perfusion (patchy pink/purple appearance which either remained or 
improved during EVKP - 2 points) 
Grade III: Poor perfusion (global mottling and purple/black appearance which remained 
throughout EVKP - 3 points). 
 
Derivation of EVKP assessment score 
A combination of the macroscopic and functional parameters were used to create an 
index of organ quality. Receiver operating characteristic (ROC) curves were previously used 
to determine thresholds of renal blood flow and urine output to differentiate between 
macroscopic grades I and II versus grade III 8. These thresholds were combined with the 
macroscopic grade to give an overall EVKP assessment score of 1 to 5. Macroscopic grades 
I, II and III were assigned points of 1, 2 and 3, respectively. Kidneys were assessed by 2 
assessors blinded to the donor details. Kidneys with a mean renal blood flow below the 
threshold (<50ml/min/100g) were given an additional score of 1. Kidneys producing less than 
the threshold of urine output (<43ml in 60 minutes) were also given an additional score of 1. 
Therefore, overall EVKP assessment scores ranged from 1 indicating the least injury to 5, the 
most severe. This score provides a quantitative measure of functional parameters that 
supports the macroscopic appearance. 
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Histological evaluation  
A wedge renal biopsy was taken on arrival at the laboratory after the period of static 
cold storage. The tissue was fixed in 10% formal saline then embedded in paraffin wax. 
Sections from the paraffin embedded tissue were cut (4µm) and stained with Haematoxylin & 
Eosin for histopathological scoring. 
A consultant pathologist graded the sections using the Remuzzi score and assessed the 
level of acute tubular injury (ATI). Sections were graded mild, mild to moderate, moderate 
and severe for the presence of ATI. 
 
Statistics 
Continuous data are presented as mean ± SD.  Data was compared using Kruskal – 
Wallis test with Dunn’s multiple comparisons test were appropriate. Categorical variables 
were analysed by Chi-squared. P < 0.050 was considered statistically significant. Donor 
factors (age, retrieval creatinine, the warm ischaemic time and cold ischaemic time) and 
perfusion parameters (The EVKP score, renal blood flow, oxygen consumption, oxygen 
extraction, urine output, percentage creatinine fall and fractional excretion of sodium) were 
correlated with the urinary biomarkers score using linear regression (Pearsons). The kidney 
donor risk index (KDRI) was calculated 11 and correlated with the EVKP score.  GraphPad 
Prism 6 was used for statistical analysis (GraphPad Software, La Jolla, California, USA). 
 
Results 
Fifty six kidneys from 41 donors were included in the study. The kidneys were 
declined for transplantation due to the following reasons. Donor history (n = 12), poor in-situ 
flush (n = 9), hypothermic machine perfusion parameters (n = 6), anatomical/technical 
reasons (n = 14), suspected malignancy (n = 6), acute kidney injury (AKI) (n = 1), histology 
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score (n = 3), fat embolism (n = 2), infection (n = 1), prolonged cold ischaemia (n = 1) and no 
suitable recipient (n = 1). The EVKP scores were as follows: Twenty two scored 1, 16 scored 
2, 8 scored 3, 4 scored 4 and 6 scored 5. To simplify analysis, the kidneys were grouped as 
follows: Group A, EVKP score 1 or 2 (n = 38), Group B, EVKP score 3 (n = 8) and Group C, 
EVKP score 4 or 5 (n = 10).  
 
Donor demographics 
There were significantly fewer female donors in the EVKP group B and C kidneys 
compared to group A (P = 0.034; Table 1). In the EVKP group B kidneys all the donors 
where from DBD donors, whereas in EVKP group C, all where from DCD donors (P = 0.001; 
Table 1).  There was no significant difference in the duration of warm or cold ischaemia (P = 
0.581, 0.051, respectively). The terminal serum creatinine was significantly higher in EVKP 
group C kidneys compared to group A (P = 0.001; Table 1). Nine out of the 10 donors in 
EVKP group C kidneys had a raised terminal serum level (>121µmol/L).  
 
Perfusion Parameters and Urinary Biomarkers 
Kidneys in EVKP group A had improved perfusion parameters compared to groups B 
and C. The renal blood flow, oxygen consumption and urine output were significantly higher 
in group A compared to groups B and C (P <0.05; Table 2). Serum creatinine fall was also 
significantly greater in group A compared to the group C (P <0.05; Table 2). There was no 
significant difference in the level of fractional excretion of sodium between the groups 
although, levels were numerically higher in group B and C kidneys (P = 0.317; Table 2). 
Levels of ET-1 were significantly higher in EVKP group B kidneys compared to the A (P = 
0.008; Figure 1a). Although, numerically levels were the highest in EVKP group C kidneys. 
NGAL was significantly lower in EVKP group A kidneys compared to group C (P = 0.018; 
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
10 
 
Figure 1b). There was no significant difference in the urinary levels of KIM-1 between the 
groups (P = 0.649; Figure 1c). 
Higher urinary levels of ET-1 and NGAL were associated a higher EVKP assessment 
score (R2 = 0.1771; P = 0.001, R2 = 0.0997; P = 0.018, respectively). There was no 
correlation with the assessment score and KIM-1 (R2 = 0.00532; P = 0.600).  
Lower urinary levels of NGAL were associated with a higher mean renal blood flow (P = 
0.008; R2 0.1890), higher level of oxygen consumption (P = 0.004; R2 = 0.1440), increased 
urine output (P = 0.049; R2 = 0.070) and decrement in creatinine (P = 0.0013; R2 = 0.1850). 
Lower urinary levels of ET-1 were associated with a greater decrement in creatinine (P = 
0.001; R2 = 0.1938). There was no significant correlation between the urinary levels of KIM-
1 and any of the perfusion parameters.  
 
Correlation of perfusion parameters with donor demographics 
There was no association with the donor age or length of warm or cold ischaemia and 
any of the perfusion parameters (P>0.05). Kidneys from female donors were associated with 
higher urine output (P = 0.0001; R2 = 0.2367), a greater decrement in creatinine (P <0.0001; 
R2 = 0.2624) and a lower EVKP score (P = 0.001; R2 = 0.1528). A higher serum creatinine 
level before retrieval was associated a lower level of renal blood flow, oxygen consumption, 
higher oxygen extraction and a lower level of renal function during EVKP (P >0.05; Table 3). 
It was also associated with a higher EVKP score. There was no association with the level of 
fractional excretion of sodium and any of the donor demographics (P = 0.4822; Table 3). The 
KDRI score did not correlate with the EVKP score (R2 = 0.0010; P = 0.820). 
 
 
 
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
11 
 
Correlation of ET-1, NGAL and KIM-1 with donor demographics 
Higher levels of urinary ET-1 and NGAL were associated with a raised creatinine 
before retrieval in the donor (R2 = 0.1139; P = 0.014 and R2 = 0.1385; P = 0.007, 
respectively). However, there was no association with donor age, warm ischaemic time or the 
cold ischaemic time (P >0.05). There was no association with KIM-1 and donor 
demographics or creatinine levels before retrieval (R2 = 0.02458; P = 0.272). 
 
Donation after Circulatory Death versus Donation after Brain Death Kidneys 
The cold ischaemic time was significantly longer in the DBD kidneys compared to the 
DCD (P 0.026; Table 4). Urinary levels of ET-1 were significantly lower in the DCD kidneys 
compared to DBD (P = 0.043; Table 4). There were no other significant differences between 
the donor demographics, perfusion parameters or urinary biomarkers (Table 4). 
 
Histology 
Thirty two biopsies were available from EVKP group A kidneys, all of group B 
kidneys and from 7/10 of group C kidneys. The median Remuzzi score was 4 (range 0-10) in 
EVKP group A kidneys, 5 in group B (range 1-10) and 3 (range 0-6) in group C kidneys. 
Eleven out of 32 of EVKP group A kidneys had mild ATI, 5 mild to moderate and 2 
moderate ATI. One kidney in EVKP group B had mild, 1 mild to moderate and 1 moderate 
ATI. Two kidneys in EVKP group C kidneys had mild ATI and 2 had moderate ATI. There 
was no association with urinary levels of NGAL, KIM-1, ET-1 or any of the perfusion 
parameters, the Remmuzi score or the level of AKI (P >0.05). 
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Discussion 
This study demonstrates that levels of urinary ET-1 and NGAL measured after 60 
minutes of EVKP were significantly correlated with perfusion parameters during EVKP. 
These biomarkers and EVKP perfusion parameters were also significantly correlated with 
terminal renal function in the donor.  There was no association between urinary KIM-1 after 
EVKP and either perfusion parameters or terminal renal function in the donor. The 
measurement of biomarkers during EVKP provides additional information about donor organ 
quality. 
Normothermic perfusion techniques are evolving as an important asset in the decision 
process to determine the suitability of an organ for transplantation. We have previously 
reported that basic functional parameters (renal blood flow and urine output) together with an 
assessment of the macroscopic appearance can be used to formulate a kidney quality score 2. 
Evidence so far suggests that a higher EVKP score is associated with an increased risk of 
DGF 2.  This technology has also been used to assess human kidneys declined for 
transplantation due to poor in-situ perfusion at the time of retrieval 10. We have subsequently 
gone onto to successfully transplant 2 of these kidneys based on this assessment 12. This 
present study has shown that other measures of function including the rate of oxygen 
consumption, oxygen   extraction and creatinine fall can be used to provide a more detailed 
assessment of function and quality.  
Measurements of serum creatinine are used clinically to assess the level of renal 
function. Nonetheless, creatinine levels are affected by other physiological functions and are 
regarded as a late marker of renal injury 4. Urinary biomarkers, particularly NGAL and KIM-
1 are sensitive measures of kidney injury and can be used to provide a more accurate 
assessment 4-6, 13, 14. In the posttransplant setting, they have a high predictive value and are 
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strongly associated with graft dysfunction. More recently Koo et al measured several 
biomarkers [NGAL, KIM-1 and liver fatty acid binding protein (L-FABP)] in a series of 94 
deceased donors to determine kidney quality and outcome 15. They used a multiple logistic 
regression model to generate a prediction score. Independently, NGAL and L-FABP were 
associated with AKI in the donor and predictive of reduced graft function in the recipient 
[area under the curve receiver operating characteristics (AUC ROC) 0.758 and 0.704, 
respectively]. When included in a scoring system their predictive value was greater (AUC 
ROC 0.808). In a larger series of 1304 deceased donors, Reese et al also found that higher 
levels of urinary NGAL were strongly associated with donor AKI and had some association 
with DGF in the recipient 16. However, their ability to predict PNF and determine which 
organs should be transplanted or discarded was low. Hollmen et al showed that in donors 
with a urinary NGAL ≥18ng/ml, DGF was more prolonged and long term outcome reduced. 
Interestingly, in all these studies KIM-1 had no association with donor AKI or outcome 17. 
NGAL is an earlier marker of kidney injury upregulated within hours whereas KIM-1 is 
reported as a later marker, although the literature is conflicting 18 . van den Akker et al found 
that KIM-1 was not detectable in the perfusate of the graft after preservation or until day 4 
post-transplant 19.  In contrast, Field et al recently reported that KIM-1 was a promising 
marker of AKI in a series of deceased donors 20. Biomarkers have also been used during 
hypothermic machine perfusion in combination with flow and resistance parameters to 
determine quality. However, individually they had low a predictive value and could not 
distinguish between transplanted and discarded kidneys 21. 
The third biomarker used in this study ET-1, is involved in regulating renal vascular 
tone and tubular secretion of electrolytes and water. Clinically, high urinary levels have been 
associated with chronic kidney 22, 23 and polycystic kidney disease 24. In a porcine model of 
reperfusion injury, we previously found that elevated levels of ET-1 accurately reflected the 
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level of ischaemic injury 6, 7. More recently, ET-1 has been used as a marker of lung injury 
during ex-vivo lung perfusion (EVLP) 25. Perfusate levels predicted lung function and were 
associated with outcome after transplantation.  
Levels of fractional excretion of sodium a marker of tubular function and urinary 
KIM-1 were not significantly different across the grades of kidneys and not associated with 
donor AKI. Therefore, their use in this setting appears to be limited. The histology revealed a 
wide variation in the level of donor related damaged. A significant proportion of kidneys had 
evidence of acute kidney injury. Renal function is not necessarily associated with histological 
findings 25 and we found no significant correlation between the Remuzzi score, urinary 
biomarkers, donor demographics or EVKP parameters. This is in agreement with Koo et al 
who found no association with the biopsy injury score, NGAL or outcome in their series of 
deceased donor kidneys 15.  The Remuzzi score is a histological assessment of chronic renal 
damage, whereas EVKP provides functional information about acute tubular injury. The lack 
of correlation between the 2 is therefore unsurprising. This argument applies equally to the 
KDRI.  
The role of urinary biomarkers has not been previously investigated during EVKP of 
human kidneys. Although there is no follow up data on outcome, this study provides 
important information for the future development of EVKP as an assessment device. Our 
described technique of EVKP is carried out at the end of the preservation interval for 60 
minutes prior to transplantation. The technique requires some added resources but is 
straightforward and brief. We found that kidneys with a higher EVKP score, indicating lower 
quality also had reduced functional parameters and higher levels of urinary NGAL and ET-1. 
These parameters were also associated with raised levels of serum creatinine recorded in the 
donor before organ retrieval. Whilst this suggests that these biomarkers are reliable indices of 
acute tubular injury which may aid in the assessment of a kidney, it also raises the question of 
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the cost effectiveness and extra utility of measuring biomarkers in addition to the currently 
available donor data and EVKP assessment. The biomarkers are typically measured using 
ELISA techniques. Although, a point-of-care devise is available for NGAL which would 
makes its application into clinical practice relatively straightforward.   
 
Larger series are required to determine whether these biomarkers can be used as a 
reliable assessment tool in combination with EVKP to predict graft outcome. We are 
currently performing a multicentre randomised controlled trial comparing static cold storage 
with EVKP in DCD kidney transplantation which is due to be completed in 2020 
(ISRCTN15821205). Urine samples are being collected during EVKP (n = 200) for the 
analysis of a range of biomarkers including NGAL, ET-1 and L-FABP. These will be 
correlated with transplant graft outcome, donor demographics, EVKP parameters and 
histological analysis. This is likely to provide us with a more conclusive evaluation of their 
use in this setting.  
A limitation to the described EVKP technique is perhaps the short duration. Of note 
during the 60 minutes of perfusion, there was no association between any of the perfusion 
parameters or urinary biomarkers and the level of ischaemic injury. This may be explained by 
the duration and conditions necessary for these effects to become evident. Warm and cold 
ischaemic injury have a detrimental effect on graft function and outcome. The re-introduction 
of oxygenated blood mediates a series of injury processes involving activated endothelial 
cells causing vasoconstriction, the recruitment of leukocytes to the injured tissue leading to 
failure of the microcirculation and the ‘no-reflow’ phenomena 27. There is also a release of 
damage associated molecular pattern molecules which activate reactive oxygen species, 
molecular and signalling cascades 28. These events cause significant tissue injury which 
results in AKI and DGF. Although circulation is restored during EVKP, the conditions are 
Copyright © Wolters Kluwer Health. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
16 
 
designed to be protective. The absence of white cells, platelets and complement factors 
abrogate graft injury and therefore it perhaps unsurprising that the impact of ischaemic injury 
appears to be undetected during this time. Nonetheless, longer perfusion times may provide 
additional information on the impact of ischaemic injury. 
In conclusion, EVKP continues to be developed as a comprehensive pretransplant 
assessment technology/tool. The measurement of urinary biomarkers during EVKP 
undoubtedly provides additional information but it is not clear at this point whether or not 
this will improve our ability to select marginal kidneys for transplantation. As this was a 
preliminary study of a relatively small number of discarded human kidneys, further analysis 
from the randomised controlled trial will evaluate the potential value of biomarkers in 
predicting clinical allograft outcomes. 
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Figure Legends 
 
Figure 1a: Urinary levels of endothelin-1 (ET-1) in EVKP group A, B and C kidneys after 60 
minutes of ex-vivo normothermic perfusion (EVKP). (P = 0.008 Group A and B versus C). 
 
Figure 1b: Urinary levels of neutrophil gelatinase-associated lipocalin (NGAL) in EVKP 
group A, B and C kidneys after 60 minutes of ex-vivo normothermic perfusion (EVKP). (P = 
0.018 Group A versus B and C). 
 
Figure 1c: Urinary levels of kidney injury molecule - 1 (KIM-1) in EVKP group A, B and C 
kidneys after 60 minutes of ex-vivo normothermic perfusion (EVKP). (P = 0.649). 
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Figure 1 
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Table 1:  The mean donor age, gender, donor type; donation after circulatory death (DCD), 
donation after brain death (DBD), warm ischaemic time (WIT), cold ischaemic time (CIT), 
retrieval creatinine (Cr) and median Kidney donor risk index (KDRI) percentage. (* EVKP 
group A versus group B). 
 
EVKP Score Group A 
    (n =38) 
Group B  
(n = 8) 
Group C  
(n = 10) 
P value 
 
Age (y) 
 
 
61 ± 11 
 
66 ± 14 
 
54 ± 16 
 
0.162 
 
M : F 
 
 
17 : 21 
 
5 : 3 
 
9 : 1 
 
0.034 
 
DCD : DBD 
 
 
23 : 15 
 
0 : 8 
 
10 : 0 
 
0.001 
 
WIT (min) 
 
 
13.1 ± 4.4 
 
  - 
 
12.5 ± 3.6 
 
0.581 
 
CIT (h.min) 
 
 
32.2 ± 13.5 
 
35 ± 19 
 
22.7 ± 7.0 
 
0.051 
 
Retrieval Cr (µmol/L) 
 
 
88 ± 44 
 
139 ± 87 
 
233 ± 126 
 
0.001* 
KDRI (%) 86 (20 -100) 96 (53 – 100) 71 (62 – 100) 0.311 
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Table 2: The mean renal blood flow, oxygen consumption, oxygen extraction, total urine 
output, serum creatinine fall and fractional excretion of sodium (Fr ex Na+) during ex-vivo 
normothermic perfusion (EVKP) in kidneys with an EVKP score of 1 to 5. (* EVKP group A 
versus C;** EVKP group A versus B and C). 
 
EVKP Score Group A  
(n = 38) 
Group B  
(n = 8) 
Group C  
(n = 10) 
P value 
 
RBF (ml/min/100g) 
 
 
86.1 ± 27.4 
 
51.3 ± 21.5 
 
37.9 ± 19.1 
 
<0.0001** 
 
O2 Consumption 
(ml/min/g) 
 
 
60.7 ± 21.7 
 
36.7 ± 16.5 
 
30.0 ± 19.4 
 
0.001** 
 
O2 Extraction (%) 
 
 
7.37 ± 6.20 
 
10.04 ± 6.3 
 
13.5 ± 11.1 
 
0.139 
 
Urine output (ml) 
 
 
121 ± 70 
 
98 ± 96 
 
26 ± 20 
 
0.001* 
 
Cr Fall (%) 
 
 
48.1 ± 7.9 
 
36.0 ± 17.2 
 
30.7 ± 6.5 
 
0.001* 
 
Fr ex Na+ (%) 
 
 
52.4 ± 21.5  
 
63.9 ± 22.0 
 
67.6 ± 35.7 
 
0.317 
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Table 3: Pearson correlation with the terminal serum creatinine in the donor and the mean 
renal blood flow, oxygen consumption, oxygen extraction, total urine output, serum 
creatinine fall, fractional excretion of sodium (Fr ex Na+) and EVKP quality assessment 
score during ex-vivo normothermic perfusion (EVKP). 
 
 
 R
2
 P value 
 
RBF (ml/min/100g) 
 
 
0.1514 
 
0.004 
 
O2 Consumption (ml/min/g) 
 
 
0.1653 
 
0.003 
 
 
O2 Extraction (%) 
 
 
0.1295 
 
0.011 
 
Urine output (ml) 
 
 
0.1798 
 
0.002 
 
Cr Fall (%) 
 
 
0.1230 
 
<0.0001 
 
Fr ex Na+ (%) 
 
 
0.1013 
 
0.4822 
 
EVKP Score 
 
0.4201 
 
<0.0001 
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Table 4: Donor demographics, perfusion parameters and urinary biomarkers in donation after 
circulatory death and donation after brain death donors. 
 
 DCD DBD P Value 
 
Donor age (y) 
 
 
60.2 ± 12.0 
 
61.5 ± 14.3 
 
0.721 
 
M : F 
 
22 : 11 
 
 
9 : 14 
 
0.057 
 
WIT (min) 
 
12.9 ± 4.1 
 
-  
 
CIT (h.min) 
 
27.1 ± 10.7 
 
 
36.5 ± 16.0 
 
0.026 
 
Retrieval Creatinine (µmol/L) 
 
139 ± 106 
 
104 ± 61 
 
0.292 
 
    
 
Renal Blood Flow (ml/min/100g) 
 
75.7 ± 36.3  
 
68.1 ± 25.3 
 
0.391 
 
 
Oxygen Consumption (ml/min/g) 
 
51.9 ± 24.4 
 
51.7 ± 24.6 
 
0.986 
 
 
Oxygen Extraction (%) 
 
8.7 ± 8.5 
 
9.41 ± 6.3 
 
0.733 
 
 
Urine output (ml) 
 
93 ± 74 
 
112 ± 81 
 
0.360 
 
 
Fractional Excretion of Na+ (%) 
 
59.1 ± 24.4 
 
53.7 ± 23.0 
 
0.438 
 
    
 
Endothelin-1 (pg/ml) 
 
0.46 ± 0.50 
 
0.55 ± 0.30 
 
0.043 
 
 
NGAL (ng/ml) 
 
37.8 ± 53.2 
 
47.8 ± 70.5 
 
0.551 
 
 
KIM-1 (pg/ml) 
 
1.16 ± 1.20 
 
1.68 ± 1.67 
 
0.178 
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